Eliquis patent expiry may cut employers' blood thinner spending
By Allison BellFor employers, the expiration of the patent on the brand-name blood thinner could lead to lower costs and improved patient care.
Trending Stories
Benefits & Health Care
Recommended For You
Recent Stories
More From HR Executive
Regulation & Compliance
Our Writers
2026 Advisor of the Year: Allison De Paoli
Allison De Paoli is a relentless advocate for transparent, high-impact employee benefits, driven by the belief that benefits are "not just numbers on a spreadsheet," she rejects the industry's status quo to deliver creative, fiduciary-first solutions that prioritize both fiscal health and human dignity.
BrowseMore Coverage
Live Coverage

Live Coverage

Live Coverage
Featured Event
GlobeSt Multifamily Fall Owners Forum
Note from the Editor: The multifamily industry faces no shortage of challenges, but one constant remains: the unmatched value of being in the room with the people leading market activity and driving capital decisions. GlobeSt Multifamily Owners Forum has earned its place as a gathering for owners, operators, investors, and executives who shape the market, not simply observe it. We encourage you to reserve your spot where Multifamily converges at the highest level.


















